| CH | clonal hematopoiesis |
| CHIP | clonal hematopoiesis of indeterminate potential |
| CVD | cardiovascular disease |
| DNMT3A | DNA methyltransferase 3A |
| TET2 | Tet methylcytosine dioxygenase 2 |
| HSPC | hematopoietic stem/progenitor cells |
| MDS | myelo-dysplastic syndromes |
| ASXL1 | additional sex combs-like transcriptional regulator 1 |
| AML | acute myeloid leukemia |
| TP53 | tumor protein p53 |
| JAK2 | janus kinase 2 |
| SF3B1 | splicing factor 3b subunit 1 |
| CBL | casitas B-lineage lymphoma gene |
| SRSF2 | serine and arginine rich splicing factor 2 |
| PPM1D | protein phosphatase, Mg2+/Mn2+ Dependent 1D |
| BCOR | BCL6 Corepressor |
| HF | heart failure |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| CD163 | Cluster Designation number 163, hemoglobin (Hb) scavenger receptor |
| CXCR4 | C-X-C chemokine receptor type 4 |
| CXCL12 | C-X-C chemokine ligand 12 |
| NOTCH1 | Notch homolog 1, translocation-associated |
| MPN | myeloproliferative neoplasms |
| NET | neutrophil extracellular traps |
| CRP | C-reactive protein |
| SHP2 | src homology region 2 (SH2)-containing protein tyrosine phosphatase 2 |
| STAT3 | signal transducer and activator of transcription 3 |
| CMN | chronic myeloproliferative neoplasia |
| CSC | cardiac stem/progenitors cells |
| SASP | senescence-associated secretory phenotype |
| ECM | extracellular matrix |
| CRISPR | clustered regularly interspaced short palindromic repeats |
| hs-CRP | high sensitivity C-reactive protein |